Demonstration of anti-asialo GM1 antibody and its neurocytotoxicity in the sera of systemic lupus erythematosus patients
Hoshino, C.; Shinomiya, N.; Yata, J.
Asian Pacific Journal of Allergy and Immunology 2(2): 195-201
1984
ISSN/ISBN: 0125-877X PMID: 6532472 Document Number: 237873
Document emailed within 1 workday
Related Documents
Kohno, Y.; Naito, N.; Saito, K.; Hoshioka, A.; Niimi, H.; Nakajima, H.; Hosoya, T. 1989: Anti-thyroid peroxidase antibody activity in sera of patients with systemic lupus erythematosus Clinical and Experimental Immunology 75(2): 217-221Tomii, M. 1981: Anti-DNA activity in Raji cell eluates of sera from patients with systemic lupus erythematosus Ryumachi 21 Suppl: 123-127
Teplizki, H.; Buskila, D.; Argov, S.; Isenberg, D.; Coates, A.R.; Sukenik, S.; Horowitz, J.; Shoenfeld, Y. 1987: Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement Journal of Rheumatology 14(3): 507-511
Almogren, A. 2010: Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus Saudi Medical Journal 31(1): 32-36
Zhang, F.-C.; Liu, L.; Xu, D. 2007: Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome Zhonghua Yi Xue Za Zhi 87(1): 7-10
Salazar-Páramo, M.; García-de la Torre, I.; Hernández-Vazquez, L.; Ortíz-Cadena, A. 1989: Evidence of a new antigen-antibody system (anti-Mic-1) in patients with systemic lupus erythematosus and hyperthyroidism Journal of Rheumatology 16(2): 175-180
Manent-Ducreuzet, C.; Margulis, J.; Kahn, M.F. 1981: Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(11): 705-712
Shrier, D.A.; Taniguchi, O.; Barnett, E.V. 1984: Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera Journal of Rheumatology 11(2): 182-187
Mach, P.S.; Kharouby, M.; Lutcher, F.; Olivier, J.L.; Bazely, N.; Dougados, M.; Amor, B. 1984: The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus Clinical and Experimental Immunology 57(3): 535-540
Tanaka, Y.; Saito, K.; Suzuki, H.; Eto, S.; Yamashita, U. 1989: Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression Journal of Immunology 143(5): 1584-1590
Okuda, M. 1976: Heterogeneity and etiological significance of anti-DNA antibody in systemic lupus erythematosus. Analysis of new DNA-anti DNA immune complexes in the circulatory blood Nihon Rinsho. Japanese Journal of Clinical Medicine 34(4): 738-745
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Arvieux, J.; Roussel, B.; Ponard, D.; Colomb, M.G. 1991: Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation Clinical and Experimental Immunology 84(3): 466-471
Ludivico, C.L.; Zweiman, B.; Myers, A.R.; Hebert, J.; Green, P.A. 1980: Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus Journal of Rheumatology 7(6): 843-849
Tang, F.L.; Dong, Y.; Chang, P.Z. 1990: Detection and clinical significance of anti-histone antibody in systemic lupus erythematosus and rheumatoid arthritis Zhonghua Nei Ke Za Zhi 29(4): 221-223; 253
Morimoto, C.; Sano, H.; Abe, T.; Homma, M.; Steinberg, A.D. 1982: Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes Journal of Immunology 129(5): 1960-1965
Winfield, J.B.; Shaw, M.; Minota, S. 1986: Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus Journal of Immunology 136(9): 3246-3253
Sabugo, F.; Llanos, C.; Soto, L.; Gutiérrez, J.; Cuchacovich, M. 2005: Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus: report of one case Revista Medica de Chile 133(6): 681-684
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Ueda, A.; Kusaba, T.; Yanase, T. 1983: Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus Clinical and Experimental Immunology 53(1): 217-224